Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Paracelsian Inc (PRLN) -- Ignore unavailable to you. Want to Upgrade?

To: Judy Muldawer who wrote (4019)	12/17/1998 11:55:00 PM
From: BARRY ALLEN	Respond to of 4342

Sorry, Judy. PRLN, APPI, and PPRT are all in the same industry and I follow all three. APPI is in the same boat as PRLN awaiting a capital infusion by private placement. The deal with RP Scherer should really kick start PRLN! Good luck tomorrow. Barry

To: Judy Muldawer who wrote (4019)	12/18/1998 9:04:00 AM
From: Jonathan Schonsheck	Read Replies (2) \| Respond to of 4342

Judy, Robin, Larry, paul, and all the rest - I don't know whether this Press Release will have any impact. (I'm too tired of being mistaken about what moves this stock to even hazard a guess.) But what I find really encouraging: 1. This infusion of capital "bridges" us to the Scherer revenue stream - ensuring the continuing viability of the Company. 2. When I first saw the figure $250,000 I was wishing it had been higher - a "louder" vote of confidence. But upon reflection, it's a good thing that we don't need more cash to continue operations. 3. The sentence "We also have generated significant interest in the marketplace." As retailers sign up for BioFIT Certification, there will be work to do, which will generate profits. But more importantly, it will generate royalty fees, which are almost PURE profit. 4. "We also are engaged in discussions with several parties regarding other aspects of our business." There's (far) more to Paracelsian than BioFIT. Natural products could yield nice profits. So could the successful marketing of the AH-Immunoassay. And pharmaceuticals - well, that's where we have the greatest potential for mega-bucks in the form of licensing arrangements. 5. "Related announcements will be forthcoming at the appropriate time." Of course they can't announce news without news. But the wait for good news - since August - has been pretty tough. We may have to wait until the potential becomes actual. But all the evidence points towards the success of our new management and board. Jonathan P.S. Hank - are you watching?